{"identifier":"nobleid:/w1/20260526/835B6182","arkIdentifier":"ark:/48914/w1/20260526/835B6182","version":1,"workTitle":"Lorlatinib Versus Crizotinib in Patients With Advanced\n            <i>ALK</i>\n            -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study","workType":"Journal Article","authors":"Benjamin J. Solomon, Geoffrey Liu, Enriqueta Felip, Tony S.K. Mok, Ross A. Soo, Julien Mazieres, Alice T. Shaw, Filippo de Marinis, Yasushi Goto, Yi-Long Wu","description":null,"workUrl":null,"createdAt":"2026-05-26T04:04:43.528112Z","canonicalUrl":"https://nobleid.org/ark:/48914/w1/20260526/835B6182.v1"}